Optiray 350 and Xeroderma pigmentosa - a phase IV clinical study of FDA data
We study 1,470 people who take Optiray 350 or have Xeroderma pigmentosa. No report of Xeroderma pigmentosa is found in people who take Optiray 350.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Optiray 350?
Optiray 350 has active ingredients of ioversol. eHealthMe is studying from 1,470 Optiray 350 users for its effectiveness, alternative drugs and more.
What is Xeroderma Pigmentosa?
Xeroderma pigmentosa: no further information found.
Do you take Optiray 350 and have Xeroderma pigmentosa?Check whether Xeroderma pigmentosa is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Xeroderma pigmentosa and when was it recovered:
Expand to all the drugs that have ingredients of ioversol:
Alternative drugs to, pros and cons of Optiray 350:
- Optiray 350 (1,470 reports)
Xeroderma pigmentosa treatments and more:
COVID vaccines that are related to Xeroderma pigmentosa:
- Xeroderma pigmentosa in Moderna COVID Vaccine
- Xeroderma pigmentosa in Pfizer BioNTech Covid Vaccine
- Xeroderma pigmentosa in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Xeroderma pigmentosa:
All the conditions that are associated with Xeroderma pigmentosa:
How the study uses the data?
The study uses data from the FDA. It is based on ioversol (the active ingredients of Optiray 350) and Optiray 350 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Zyrtec and Skin Burning Sensation - 12 seconds ago
- Coffee and Amoxicillin drug interaction - 52 seconds ago
- Ibu and Muscle Twitching - 52 seconds ago
- Clopidogrel and Mouth Haemorrhage - 52 seconds ago
- Ritalin and Flagyl Er drug interaction - 58 seconds ago
- Mixtard Human 70/30 and Amlodipine drug interaction - 58 seconds ago
- Carbamazepine and Hiccups - a minute ago
- Cleocin and Drug Hypersensitivity - a minute ago
- Vitamin C and Osteoma - a minute ago
- Hydrocodone Bitartrate And Acetaminophen and Thrombosis - a minute ago